Tag Archives: cipla

IPAB members’ appointment provisions unconstitutional: MHC

In a recent ruling, the Madras High Court struck down provisions of Intellectual Property Appellate Board appointments under the Trademarks Act as unconstitutional citing the violation of separation of powers and independence of judiciary by the government. The Court was … Continue reading

Posted in Administrative Law, Constitution Law, Intellectual Property Law, International Law, patent law, Trade Law | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Cipla restrained to make generic COPD drug: DHC

The Delhi High Court restrained domestic pharma company Cipla from producing and marketing a generic version of Novartis drug ‘Onbrez’ used for treating Chronic Obstructive Pulmonary Disease. Novartis sued Cipla for infringement of its Indian patents for drug ‘Onbrez’ containing Indacaterol … Continue reading

Posted in Intellectual Property Law, International Law, patent law, Trade Law | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Glenmark restrained from producing anti-diabetic drug: DHC

The Delhi High Court restrained Glenmark Pharmaceuticals from producing and marketing a generic version of Merck’s drug ‘Januvia’ used for treating diabetes. Merck sued Glenmark for infringement of its Indian patent for ‘Januvia’ and ‘Janumet’. Glenmark was selling the generic version … Continue reading

Posted in Intellectual Property Law, International Law, patent, trademark | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Novartis cancer drug patent application rejected for lack of enhancement of efficacy: SC

In a very important ruling, the Supreme Court of India rejected a patent application by Novartis for a major cancer drug on the ground that the application was not an invention per Section 3(d) of the Patent Act. The Court … Continue reading

Posted in Intellectual Property Law, International Law | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Cipla not infringing Pfizer patent for drug Tarceva: DHC

In a big relief to pharmaceutical company Cipla Ltd. (“Cipla”), the Delhi High Court ruled that Cipla did not infringe OSI/Pfizer (“Pfizer”) Indian patent for their drug ‘Erlotinib’ (trade name ‘Tarceva’) by manufacture, marketing and sale of their drug ‘Erlocip’, … Continue reading

Posted in Intellectual Property Law | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment